Embecta

Embecta Cash Ratio

The Cash Ratio of Embecta (EMBC) as of Oct 18, 2026 is 0.53. In the previous year, Cash Ratio was 0.48 — a change of 11.90% (higher).

Cash Ratio

0.53

YoY

11.90%

Last updated:

Cash Ratio of Embecta is 2025 0.53 . Cash Ratio of Embecta was 2024 0.48 . It decreases by 11.90% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Embecta Stock analysis

What does Embecta do? Embecta Corp, headquartered in Parsippany, New Jersey, operates in the Health Care sector, manufacturing and distributing medical devices for diabetes treatment. The company employs 1,850 full-time staff and offers a portfolio including pen needles, syringes, safety injection devices, and a digital application for diabetes management. Its products, such as sterile single-use pen needles and safety pen needles with automatic shields, are designed to enhance user safety and convenience. Embecta distributes through retail, hospital, pharmacy, and institutional channels. Embecta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Embecta stock

Cash Ratio of Embecta is 0.53 in 2025.

Cash Ratio of Embecta changed from 0.48 to 0.53, representing a 11.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Ratio Embecta since 2006 – with annual values, charts, and detailed analysis.

The Cash Ratio is the most conservative liquidity metric, comparing only cash and equivalents to current liabilities.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Ratio's Embecta with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Embecta

All Key Metrics — Embecta